Key facts
- This page summarizes Alexis Borisy's Form 4 filing for Magenta Therapeutics, Inc. (DNTH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Sep 2021, 16:47.
Alexis Borisy - 26 Aug 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)
- Reporting relationship
- Director
- Issuer ticker
- DNTH
- Reported as of
- 26 Aug 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Sep 2021, 16:47:15 UTC
- Prior SEC filing
- 12 Aug 2021
- Next SEC filing
- 20 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cindy Driscoll, Attorney-in-Fact for Alexis Borisy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexis Borisy filed Form 4 for Magenta Therapeutics, Inc. (DNTH) on 23 Sep 2021.
Change
- Previous filing in this sequence was filed on 12 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MGTA
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +4,100
- Change %
- Price
- $0.000000
- Shares after
- 4,100
- Date
- 26 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pro rata distribution from Third Rock Ventures GP IV, L.P., of which the reporting person is a limited partner.